
|Articles|September 7, 2016
How Many Opioids Have Received ADP Designation on the Basis of Category 1 Studies Alone?
J. David Haddox, DDS, MD, corrects a misconception about opioids with abuse-deterrent properties.
Advertisement
J. David Haddox, DDS, MD, corrects a misconception about opioids with abuse-deterrent properties.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Nipah Outbreak in India Poses Low Global Risk Despite Lack of Approved Treatments
2
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
3
Q&A: Making Plant-Based Eating Practical in Pharmacy-Led Cardiometabolic Care
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5


























